Men's Health News RSS Feed - Men's Health News

Study: Certain prostate cancer medications linked to cardiac death risk

Study: Certain prostate cancer medications linked to cardiac death risk

A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart attacks. Published in BJU International, the findings will help doctors and patients weigh the benefits and risks of the drugs. [More]
UW-Madison receives $8.3 million NIH grant to create new urological research center

UW-Madison receives $8.3 million NIH grant to create new urological research center

The University of Wisconsin-Madison has been awarded an $8.3 million grant from the National Institutes of Health to create a research center focused on urological health. [More]
Myriad's Prolaris test included in NCCN Guidelines for men with localized prostate cancer

Myriad's Prolaris test included in NCCN Guidelines for men with localized prostate cancer

Myriad Genetics, Inc. today announced that its Prolaris test has been included in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) for all men with localized prostate cancer, regardless of their risk category. [More]
UAB offers MRI-US image fusion technique for prostate cancer detection

UAB offers MRI-US image fusion technique for prostate cancer detection

The latest advancement in prostate cancer detection is magnetic resonance imaging and ultrasound fusion-guided biopsy, which offers benefits for both patient and physician. [More]
New research suggests that exposure to aluminium may reduce male fertility

New research suggests that exposure to aluminium may reduce male fertility

And the team of scientists, at the universities of Lyon and Saint-Etienne in France and Keele in the UK, found that the higher the aluminium, the lower sperm count. [More]
UB study: Males with IBS experience more interpersonal difficulties than females

UB study: Males with IBS experience more interpersonal difficulties than females

One of the few studies to examine gender differences among patients with irritable bowel syndrome (IBS) has found that males with the condition experience more interpersonal difficulties than do females with the condition. [More]
IOF data shows 93% of US adults are unaware of men’s susceptibility to osteoporosis

IOF data shows 93% of US adults are unaware of men’s susceptibility to osteoporosis

New survey findings released by the International Osteoporosis Foundation (IOF) for World Osteoporosis Day show that on average, 93 percent of nearly 1,200 adults surveyed are unaware how common osteoporotic fractures are in men. [More]
CMS publishes draft coverage decision for Decipher Prostate Cancer Classifier

CMS publishes draft coverage decision for Decipher Prostate Cancer Classifier

GenomeDx Biosciences today announced that a draft local coverage determination (LCD) for its Decipher® Prostate Cancer Classifier has been published by the Centers for Medicare and Medicaid Services (CMS) describing a coverage and payment policy for use of the Decipher test in men who have undergone radical prostatectomy. [More]
New combination therapy shows promise in treating prostate cancer

New combination therapy shows promise in treating prostate cancer

Like discriminating thieves, prostate cancer tumors scavenge and hoard copper that is an essential element in the body. But such avarice may be a fatal weakness. [More]

Urologists evaluate physician adherence to AUA's BPH/LUTS guidelines

Evidence-based guidelines play an increasing role in setting standards for medical practice and quality but are seldom systematically evaluated in the practice setting. Investigators evaluated the rate of physician adherence to the American Urological Association's guidelines on the management of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS) to establish a benchmark for future research. [More]
UCSF researcher awarded Jim Lafferty Memorial Research Grant for early detection of prostate cancer

UCSF researcher awarded Jim Lafferty Memorial Research Grant for early detection of prostate cancer

ZERO - The End of Prostate Cancer recently awarded the Jim Lafferty Memorial Research Grant in the amount of $45,000 to Peter Carroll, M.D., M.P.H., of UC San Francisco for the purpose of researching new and improved methods for early detection of prostate cancer. [More]
Men and women have different cardiovascular, psychological reactions to mental stress

Men and women have different cardiovascular, psychological reactions to mental stress

Men and women have different cardiovascular and psychological reactions to mental stress, according to a study of men and women who were already being treated for heart disease. [More]
HIV-infected users of stimulants derive benefits from antiretroviral therapy

HIV-infected users of stimulants derive benefits from antiretroviral therapy

New clinical research from UC San Francisco shows that 341 HIV-infected men who reported using stimulants such as methamphetamine or cocaine derived life-saving benefits from being on antiretroviral therapy that were comparable to those of HIV-infected men who do not use stimulants. [More]
RNA molecules in tissue, urine samples can detect prostate cancer

RNA molecules in tissue, urine samples can detect prostate cancer

Researchers at Sanford-Burnham Medical Research Institute have identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients but not in normal healthy individuals. [More]
Testosterone therapy raises risk of prostate tumors in rats

Testosterone therapy raises risk of prostate tumors in rats

A researcher who found that testosterone raised the risk of prostate tumors and exacerbated the effects of carcinogenic chemical exposure in rats is urging caution in prescribing testosterone therapy to men who have not been diagnosed with hypogonadism, according to a new study published in the Endocrine Society's journal Endocrinology. [More]
Suicide prevention: an interview with Dr Shekhar Saxena, World Health Organization

Suicide prevention: an interview with Dr Shekhar Saxena, World Health Organization

Suicide is a serious public health problem. More than 800,000 people die from suicide every year – that’s one person every 40 seconds. [More]
Researchers identify biomarker that can predict GS7 prostate cancer patients

Researchers identify biomarker that can predict GS7 prostate cancer patients

Researchers at The University of Texas MD Anderson Cancer Center have identified a biomarker living next door to the KLK3 gene that can predict which GS7 prostate cancer patients will have a more aggressive form of cancer. [More]

Findings may shed light on risk factors associated with problem drinking among men

Consuming an alcoholic beverage may make men more responsive to the smiles of others in their social group, according to new research in Clinical Psychological Science, a journal of the Association for Psychological Science. The findings suggest that, for men, alcohol increases sensitivity to rewarding social behaviors like smiling, and may shed light on risk factors that contribute to problem drinking among men. [More]
Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC). [More]
ED more prevalent than previously thought

ED more prevalent than previously thought

Specialists in treatment of erectile dysfunction recognize that ED is more prevalent than previously recognized. [More]